In addition to its role in activating Wnt/β-catenin and Hippo signaling pathways in colon cancers, KDM3A activates the gene transcription of 15-lipoxygenase-1 (15-LOX-1), which is silenced in cancer cells [47]. Here, KDM3A is linked to cancer.